Prof. Joanna Thomas is an Associate Professor of Biomedical Engineering and a Coordinator for Research and BEAR Day at the School of Engineering, Mercer University, USA. After completing her Ph.D. in Bioengineering at the University of California San Diego, she worked in the biomedical device industry and academic research before joining the Mercer faculty in 2016. She teaches the Tissue and Cell Engineering course sequence for the Biomedical Engineering Department and oversees Mercer’s REU How To program. Her research is focused on the design and fabrication of medical devices and therapies (and systems to test them) to treat hepatobiliary diseases such as primary sclerosing cholangitis. She is interested in utilizing biomaterials in the treatment of human disease and tissue regeneration. She has a particular interest in hepatobiliary diseases because there is an unmet need for new or improved treatments for autoimmune liver diseases such as primary sclerosing cholangitis. In the lab, she is working to design and fabricate 3D printed devices and testing equipment focusing on new ways to deliver drugs to their cell and tissue targets. She has experience evaluating novel compounds for their efficacy in vitro and in vivo. She also has a working knowledge of device design and material biocompatibility from her time in bioprosthetic heart valve R&D.
Prof. Joanna Thomas is an Associate Professor of Biomedical Engineering and a Coordinator for Research and BEAR Day at the School of Engineering, Mercer University, USA. After completing her Ph.D. in Bioengineering at the University of California San Diego, she worked in the biomedical device industry and academic research before joining the Mercer faculty in 2016. She teaches the Tissue and Cell Engineering course sequence for the Biomedical Engineering Department and oversees Mercer’s REU How To program. Her research is focused on the design and fabrication of medical devices and therapies (and systems to test them) to treat hepatobiliary diseases such as primary sclerosing cholangitis. She is interested in utilizing biomaterials in the treatment of human disease and tissue regeneration. She has a particular interest in hepatobiliary diseases because there is an unmet need for new or improved treatments for autoimmune liver diseases such as primary sclerosing cholangitis. In the lab, she is working to design and fabricate 3D printed devices and testing equipment focusing on new ways to deliver drugs to their cell and tissue targets. She has experience evaluating novel compounds for their efficacy in vitro and in vivo. She also has a working knowledge of device design and material biocompatibility from her time in bioprosthetic heart valve R&D.